1. 832 Unravelling human melanoma heterogeneity by 6-color multiplex immunofluorescence to overcome recurrence and resistance to therapy. (9th November 2020) Authors: Willemsen, Marcella; Bulgarelli, Jenny; Kumar, Sudhir; Guidoboni, Massimo; Kyte, John; Davidson, Irwin; Luiten, Rosalie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 832 Unravelling human melanoma heterogeneity by 6-color multiplex immunofluorescence to overcome recurrence and resistance to therapy. (9th November 2020) Authors: Willemsen, Marcella; Bulgarelli, Jenny; Kumar, Sudhir; Guidoboni, Massimo; Kyte, John; Davidson, Irwin; Luiten, Rosalie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study. Issue 3 (April 2020) Authors: Ridolfi, Laura; De Rosa, Francesco; Petracci, Elisabetta; Tanda, Enrica Teresa; Marra, Elena; Pigozzo, Jacopo; Marconcini, Riccardo; Guida, Michele; Cappellini, Gian Carlo Antonini; Gallizzi, Giulia; Occelli, Marcella; Pala, Laura; Gambale, Elisabetta; Bersanelli, Melissa; Galdo, Giovanna; Cortel... Journal: Journal of geriatric oncology Issue: Volume 11:Issue 3(2020) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis. (November 2022) Authors: Corrie, Pippa; Meyer, Nicolas; Berardi, Rossana; Guidoboni, Massimo; Schlueter, Maximilian; Kolovos, Spyros; Macabeo, Bérengère; Trouiller, Jean-Baptiste; Laramée, Philippe Journal: Cancer treatment reviews Issue: Volume 110(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). Issue 8 (5th August 2018) Authors: Ridolfi, Laura; de Rosa, Francesco; Fiammenghi, Laura; Petrini, Massimiliano; Granato, Anna Maria; Ancarani, Valentina; Pancisi, Elena; Soldati, Valentina; Cassan, Serena; Bulgarelli, Jenny; Riccobon, Angela; Gentili, Giorgia; Nanni, Oriana; Framarini, Massimo; Tauceri, Francesca; Guidoboni, Massimo Journal: BMJ open Issue: Volume 8:Issue 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab. (July 2018) Authors: Queirolo, Paola; Dozin, Beatrice; Morabito, Anna; Banelli, Barbara; Carosio, Roberta; Fontana, Vincenzo; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Ascierto, Paolo A.; Madonna, Gabriele; Simeone, Ester; De Galitiis, Federica; Antonini Cappellini, Gian Carlo; Marchetti, Paol... Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dabrafenib–trametinib combination in 'field-practice': an Italian experience. (7th August 2018) Authors: Depenni, Roberta; De Rosa, Francesco; Greco, Stefano; Ridolfi, Laura; Pellacani, Giovanni; Ponti, Giovanni; Cascinu, Stefano; Guidoboni, Massimo Journal: Future oncology Issue: Volume 14:Number 20(2018) Page Start: 2045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience. Issue 4 (August 2017) Authors: de Rosa, Francesco; Ridolfi, Laura; Fiammenghi, Laura; Petrini, Massimiliano; Granato, Anna M.; Ancarani, Valentina; Pancisi, Elena; Soldati, Valentina; Cassan, Serena; Bulgarelli, Jenny; Framarini, Massimo; Tauceri, Francesca; Migliori, Giuseppe; Brolli, Claudia; Gentili, Giorgia; Petracci, Elis... Journal: Melanoma research Issue: Volume 27:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to "Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis" [Cancer Treat. Rev. 110 (2022) 102463]. (January 2023) Authors: Corrie, Pippa; Meyer, Nicolas; Berardi, Rossana; Guidoboni, Massimo; Schlueter, Maximilian; Kolovos, Spyros; Macabeo, Bérengère; Trouiller, Jean-Baptiste; Laramée, Philippe Journal: Cancer treatment reviews Issue: Volume 112(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. (October 2018) Authors: Ridolfi, Laura; De Rosa, Francesco; Petracci, Elisabetta; Gentili, Giorgia; Nanni, Oriana; Farolfi, Alberto; Casadei, Carla; Rossi, Alice; Gentili, Nicola; Guidoboni, Massimo Journal: Medical hypotheses Issue: Volume 119(2018) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗